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7 ABSTRACT: A photochemical approach to the cytotoxic lactone
8 (+)-goniofufurone (1) is reported. Paterno−̀Büchi [2 + 2] photo-
9 cycloaddition from known enol ether 4, derived from the readily
10 available sugar D-isosorbide, yielded oxetane 7. This slow, dilute
11 reaction was scaled up by using ﬂow photochemistry to yield >40 g of
12 7. Installation of the key lactone ring was achieved via a unique Wacker-
13 style oxidation of an enol−ether bond. Acid-catalyzed aqueous ring
14 opening provided 1 in ﬁve steps from 4 (11.5% overall).
15 (+)-Goniofufurone (1) is an example of a number of styryl-
16 lactone containing natural products isolated from Goniothala-
17 mus trees of the plant family Annonaceae in South East Asia.1
18 Extracts from these plants have been used as traditional
19 medicines in the treatment of edema and rheumatism as well as
20 mosquito repellents. A number of total synthesis of 1 and its
21 congeners have been reported,2 as well as progress in the
22 synthesis and evaluation of biological activity of analogues. Of
23 particular signiﬁcance is the extensive work of Popsavin et al.3
24 who have demonstrated that analogues of 1 have potent
25 antiproliferative eﬀects against a number of human cell lines. In
26 particular, the oxetane 2, which was formed from 7-epi-
27 (+)-goniofufurone, had a cytotoxic potency greater than that of
28 the natural product and, with some cell lines, even greater
f1 29 activity than the anticancer drug standard doxorubicin (Figure
f1 30 1).
31 As part of a program exploring the use of synthetic
32 photochemistry in drug discovery, we were intrigued with the
33 possibility of synthesizing 1 by hydrolysis of the oxetane 3,
34 which as an epimer of 2 should undergo hydrolytic inversion of
s1 35 the benzylic C-7 center during ring opening (Scheme 1). An
36eﬃcient synthesis of 3 would also prove useful for the
37preparation of a range of ring-opened analogues for use in drug
38discovery (1, Nu = OR, NHR, SR, CN, etc.). If successful ring-
39opening protocols could be developed, then a diverse range of
40nucleophiles could be investigated under protic or Lewis acid
41conditions. In order to achieve this, we proposed a route
42toward 3 that involved a Paterno−̀Büchi [2 + 2] photo-
43cycloaddition between the bicyclic enol ether 4 and
44benzaldehyde (Scheme 1).
45There have been many reports on the scope of the Paterno−̀
46Büchi reaction in the synthesis of oxetanes and their subsequent
47ring-opening reactions.4 Although this photocycloaddition has
48some signiﬁcant limitations, it often provides the most direct
49and economic route to this class of four-membered hetero-
50cycle.5 Although at this stage the stereoselectivity of 4 to 3 was
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Figure 1. IC50 values of (+)-goniofufurone (1) and oxetane analogue 2
and their comparison to anticancer drug standard doxorubicin (DOX).
Scheme 1. Proposed Oxetane Ring-Opening Strategy to
(+)-Goniofufurone and Analogues and a Concise Route
from D-Isosorbide via a Paternò−Bu ̈chi Photocycloaddition
Synthetic Strategy
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51 untested, the regiochemistry of a model photocycloaddition of
52 benzaldehyde with dihydrofuran6 was clearly in our favor.
53 Furthermore, we have shown that the model cycloaddition of
54 benzaldehyde with dihydrofuran could be scaled up very
55 eﬀectively (e.g., 150 g/24 h) using our FEP ﬂow photochemical
56 reactors.7 Thus, if the Paterno−̀Büchi photochemistry to 3
57 could be realized, then a short and scalable route to 1 and
58 analogues could be developed.
59 The requisite enantiomer of the enol ether 4 is conveniently
60 available from D-isosorbide 7 in a two-step sequence according
61 to the protocol of Berini and Deniau.8 In our hands, this was
62 found to be highly scalable, and 50 g batches of 4 could be
63 produced routinely. Irradiation of 4 with benzaldehyde in
64 acetonitrile in a batch immersion well (400 mL) with a 400 W
65 medium-pressure lamp gave a 2:1 inseparable mixture of the
66 desired oxetane 7 and a structural regioisomer 6. Although the
67 batch irradiation proceeded in good overall yield (93%), the
68 reaction was slow and required running at fairly high dilution.
69 This meant that meaningful scale up in batch was rather
70 restricted. Previously, we demonstrated7 that FEP continuous
71 ﬂow reactors can be useful in the scale up of organic
72 photochemistry, especially in the case of high dilution reactions
73 where the large volumes of solvent are not compatible with
74 ﬁxed volume batch reactors. Using a three-layer FEP ﬂow
75 reactor in conjunction with a 400 W medium-pressure lamp, we
76 were able to considerably upscale the productivity of this key
77 reaction, enabling the formation of over 40 g of the 6/7 mixture
78 (97% isolated yield) in a single 83 h run (1 mL/min, 70 min
79 residence time). We were pleased to observe the formation of 7
80 not only as the major regioisomer but also with the correct C-7
81 stereochemistry. Basic methanolysis gave a 2:1 mixture of the
82 alcohols 8 and 9, which were easily separable at this stage
s2 83 (Scheme 2).
84 With multigram quantities of 9 in hand, we then explored the
85 installation of the lactone ring. Triﬂation of 9 immediately
86 followed by DBU elimination of the resulting triﬂate gave the
87 enol ether 10 in 41% yield. The intermediate triﬂate of 9
88 proved to be rather unstable and on one occasion decomposed
89 exothermically on standing at room temperature. Unfortu-
90 nately, the corresponding less labile mesylate and tosylate of 9
91 were unreactive toward basic elimination. Despite this, we were
92 able to carry out the triﬂation/elimination of 9 on up to an 8.0
93 g scale to prepare 2.6 g (35%) batches of 10.
94 At this stage, we attempted to investigate the installation of
95 the lactone ring by direct oxidation of 10. There are a number
96 of reports in the literature regarding the direct oxidation of 5-
97 and 6-membered enol ethers to the corresponding lactones.
98 The most common of these is a chromate-based oxidation
99 system.9 Unfortunately, a number of the chromate systems
100 explored (e.g., PCC, PDC, Jones oxidation) gave rise to rapid
101 decomposition of 10, and none of the lactone−oxetane 3 could
102 be isolated. We then screened 10 under a variety of diﬀerent
103 oxidation conditions, but despite a study of over 20 oxidants10
104 we were unable to isolate any of the desired lactone 3. It
105 became frustratingly clear that many of the conditions required
106 to oxidize the enol−ether bond in 10 would always be
107 incompatible with the acid-sensitive oxetane ring. In a change
108 of strategy, we postulated that a Wacker-type oxidation may be
109 more successful as the initial step would involve a metal−π
110 interaction under mild conditions. On treatment of 10 under
111 standard Wacker conditions, we were delighted to see rapid and
112 clean oxidation to the elusive lactone 3 in 60% yield. Pleasingly,
113this reaction could be carried out on gram scale; e.g., 2.6 g of 10
114gave 1.62 g of 3 (58%).
115Initial attempts to complete the synthesis of 1 by oxetane
116ring opening proved to be very interesting. Treatment of 3 with
117dilute aqueous HCl in dioxane yielded the chloride 11 (91%),
118which after conﬁrmation by X-ray crystallography appeared to
119have undergone substitution with overall retention of C-7
120stereochemistry. However, as traces (≤5%) of 1 were also
121isolated from the reaction mixture it is likely that 1 is formed
122initially and then undergoes subsequent acid-catalyzed chloride
123substitution in an overall double-inversion sequence. Repeating
124the sequence with the less nucleophilic TsOH yielded
125(+)-goniofufurone (1) in 88% yield (Scheme 2).
126In light of the extreme diﬃculty faced in the oxidation of enol
127ether 10 to lactone 3, the surprisingly eﬀective Pd(II)-mediated
128oxidation deserves further comment. Although Pd(II) Wacker
129style oxidations of enol ethers to enones are well
130documented,11 we believe that the present result represents
131the ﬁrst example of a Wacker style oxidation of a cyclic enol
132ether to a lactone. It has been reported that the oxidation of
133dihydrofuran with PdCl2 leads to a mixture where the major
Scheme 2. Total Synthesis of (+)-Goniofufurone and X-ray
Crystallography of 1 and 11
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134 product is 2-hydroxy-3-chlorotetrahydrofuran.12 This suggests
135 that the mode of oxidation to lactone 3 is speciﬁc to the
136 particular structural features present in 10. It is reasonable to
137 propose that coordination of the alkene to Pd(II) is facilitated
138 by the furan oxygen such that it proceeds from the concave face
s3 139 of 10 to give the complex 12 (Scheme 3). Metalation proceeds
140 to give oxonium ion 13, which is unable to undergo syn β-
141 hydride elimination and as such is attacked by water from the
142 convex face to give 14. This then undergoes β-hydride
143 elimination to the enol 15 and then tautomerization to 3.
144 In conclusion, we have developed a short and scalable
145 synthesis of (+)-goniofufurone (1) in just ﬁve steps from the
146 enantiopure enol ether 4, itself a readily available starting
147 material sourced from the abundant and low cost sugar
148 derivative D-isosorbide. Key features include formation of the
149 oxetane 7 by a photochemical Paterno−̀Büchi reaction. The
150 batch limitations of this step were overcome by the use of a
151 ﬂow photoreactor allowing the synthesis of >40 g of
152 intermediates in a single run. Considering the issues faced in
153 subsequent steps, there is no doubt that it would have been
154 extremely diﬃcult to complete a meaningful total synthesis of 1
155 without this level of productivity in the Paterno−̀Büchi step.
156 This highlights the power of ﬂow chemistry techniques when
157 applied to the up-scaling of photochemistry, an area that is
158 often criticized for low productivity levels. Due to the acid
159 sensitivity of the oxetane ring, we were faced with a seemingly
160 intractable enol ether to lactone oxidation problem (10 to 3),
161 only to ﬁnd that a Pd(II) Wacker type oxidation was surprising
162 eﬀective. This novel Pd(II)-catalyzed transformation appears to
163 be speciﬁc to 10 as enol ethers are traditionally oxidized to
164 enones under Wacker conditions. Finally this study should
165 allow for the production of quantities of the oxetane−lactone 3
166 and the chloro lactone 11 as key intermediates for the synthesis
167 of C-7 analogues of (+)-goniofufurone as part of a possible
168 cancer drug-discovery program. For example, as the synthetic
169 oxetane 2 prepared by Popsavin3 has displayed high
170 cytotoxicity against human cell lines, access to large quantities
171 of 3 and other Paterno−̀Büchi-derived oxetanes could prove to
172 be medicinally important.
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Scheme 3. Proposed Mechanism for Selective Enol−Ether
Oxidation to Lactone 3 under Wacker Conditions
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241
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